Dr Ehsan Samei Ph.D. Joins Imalogix as Chief Scientific Advisor

Imalogix, an industry leader in deep learning AI for imaging, announced that world renowned radiology leader and clinical researcher Dr. Ehsan Samei has joined the Imalogix team as its Chief Scientific Advisor.

Dr. Ehsan Samei, PhD, DABR, FAAPM, FSPIE, FAIMBE, FIOMP, FACR is the Reed and Martha Rice Distinguished Professor of Radiology at Duke University, where he holds additional appointments in Medical Physics, Biomedical Engineering, Physics, and Electrical and Computer Engineering.

He is the Chief Imaging Physicist for Duke University Health System, the director of the Carl E Ravin Advanced Imaging Laboratories, and the director of the Center for Virtual Imaging Trials. Author of over 350 referred papers, his work has aimed to bridge the gap between scientific scholarship and clinical practice through patient-centric imaging and translational research. His research focuses on virtual clinical trials, quantitative imaging, and performance metrologies. He was the pioneer in introducing in vivo image quality assessment in radiological imaging, bringing in a new paradigm in the personalized assessment, assurance, and optimization of imaging in clinical practice.

“We are thrilled to be working with Dr. Samei. His world renown accomplishments are too numerous to encapsulate in a quote, but his insights and intellectual property are transformative and will be invaluable in Imalogix fulfilling its mission to Rethink Healthcare™.” said John Heil, CEO of Imalogix.

“I have always admired Imalogix for its innovative solutions and its vision to enhance medicine and its practice through holistic solutions that extend beyond radiation dose towards performance management. I am delighted to partner with such an innovative leader in the imaging community and am looking forward to advancing quality medicine together.” said Dr. Samei.

SourceImalogix

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.